Personal information

Activities

Collapse all

Employment (2)

Bristol Myers Squibb: Seattle, WA, US

2020-09 to present | Senior Associate Scientist (Engineered T cell Biology)
Employment
Source: Self-asserted source
Alexandra K. Frye

Providence: Portland, OR, US

2018-09 to 2020-09 | Research Associate II
Employment
Source: Self-asserted source
Alexandra K. Frye

Education and qualifications (2)

University of Groningen: Groningen, NL

2016-09 to 2018-08 | MSc. Biomedical Sciences
Education
Source: Self-asserted source
Alexandra K. Frye

Santa Clara University: Santa Clara, CA, US

2010-09 to 2014-03 | BSc. Public Health Sciences
Education
Source: Self-asserted source
Alexandra K. Frye

Works (3)

PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors

Journal of Clinical Investigation
2022-06-15 | Journal article
DOI: 10.1172/JCI156821
Contributors: Rebekka Duhen; Olivier Fesneau; Kimberly A. Samson; Alexandra K. Frye; Michael Beymer; Venkatesh Rajamanickam; David Ross; Eric Tran; Brady Bernard; Andrew D. Weinberg et al.
Source: check_circle
Crossref

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

Nature Communications
2021-02-16 | Journal article
DOI: 10.1038/s41467-021-21383-1
Contributors: Rebekka Duhen; Carmen Ballesteros-Merino; Alexandra K. Frye; Eric Tran; Venkatesh Rajamanickam; Shu-Ching Chang; Yoshinobu Koguchi; Carlo B. Bifulco; Brady Bernard; Rom S. Leidner et al.
Source: check_circle
Crossref

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease

Nature Communications
2019-01-18 | Journal article
DOI: 10.1038/s41467-019-08294-y
Part of ISSN: 2041-1723
Source: Self-asserted source
Alexandra K. Frye
How many people are using ORCID?